PAM-1: an antimicrobial peptide with promise against ceftazidime-avibactam resistant Escherichia coli infection

Overview of attention for article published in Frontiers in Microbiology, April 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 23,842 followers.

The most notable finding of this study is that the antimicrobial peptide PAM-1 may treat CZA-resistant E. coli infections. PAM-1's antibacterial and anti-biofilm properties, membrane integrity disruption mechanism, and low cytotoxicity and hemolysis rates

30 Apr 2024

Reply Repost Favourite

New Research: PAM-1: an antimicrobial peptide with promise against ceftazidime-avibactam resistant Escherichia coli infection https://t.co/xbn3HqrArA #microbiology

30 Apr 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.